Source: Hormone and Metabolic Research. Unidade: FM
Assunto: ENDOCRINOLOGIA
ABNT
KNOEPFELMACHER, M et al. Calcium and prolactin secretion in humans: effects of the channel blocker , verapamil , in the spontaneous and drug-induced hyperprolactinemia. Hormone and Metabolic Research, v. 26, n. 10, p. 481-5, 1994Tradução . . Acesso em: 24 jul. 2024.APA
Knoepfelmacher, M., Villares, S. M., Nicolau, W., Germeck, O. O., Lerario, A. C., Wajchenberg, B. L., & Liberman, B. (1994). Calcium and prolactin secretion in humans: effects of the channel blocker , verapamil , in the spontaneous and drug-induced hyperprolactinemia. Hormone and Metabolic Research, 26( 10), 481-5.NLM
Knoepfelmacher M, Villares SM, Nicolau W, Germeck OO, Lerario AC, Wajchenberg BL, Liberman B. Calcium and prolactin secretion in humans: effects of the channel blocker , verapamil , in the spontaneous and drug-induced hyperprolactinemia. Hormone and Metabolic Research. 1994 ;26( 10): 481-5.[citado 2024 jul. 24 ]Vancouver
Knoepfelmacher M, Villares SM, Nicolau W, Germeck OO, Lerario AC, Wajchenberg BL, Liberman B. Calcium and prolactin secretion in humans: effects of the channel blocker , verapamil , in the spontaneous and drug-induced hyperprolactinemia. Hormone and Metabolic Research. 1994 ;26( 10): 481-5.[citado 2024 jul. 24 ]